EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 80 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $599,113 | -56.7% | 1,964,302 | 0.0% | 0.00% | – |
| Q2 2023 | $1,382,869 | -28.9% | 1,964,302 | -9.4% | 0.00% | – |
| Q1 2023 | $1,944,841 | -20.1% | 2,168,404 | +5.1% | 0.00% | – |
| Q4 2022 | $2,433,893 | -84.1% | 2,062,621 | +1.6% | 0.00% | – |
| Q3 2022 | $15,291,000 | +26.5% | 2,030,583 | +5.8% | 0.00% | – |
| Q2 2022 | $12,092,000 | -13.8% | 1,919,336 | +13.6% | 0.00% | – |
| Q1 2022 | $14,020,000 | +59.2% | 1,689,243 | -0.5% | 0.00% | – |
| Q4 2021 | $8,809,000 | -22.3% | 1,697,521 | +0.1% | 0.00% | – |
| Q3 2021 | $11,333,000 | -21.1% | 1,696,525 | +0.7% | 0.00% | – |
| Q2 2021 | $14,358,000 | -0.3% | 1,685,128 | +3.5% | 0.00% | – |
| Q1 2021 | $14,405,000 | -26.3% | 1,627,738 | +2.3% | 0.00% | -100.0% |
| Q4 2020 | $19,549,000 | +81.0% | 1,590,613 | +19.9% | 0.00% | – |
| Q3 2020 | $10,803,000 | -13.2% | 1,327,022 | +2.3% | 0.00% | – |
| Q2 2020 | $12,450,000 | +43.9% | 1,296,905 | +1.9% | 0.00% | – |
| Q1 2020 | $8,654,000 | -51.7% | 1,272,480 | +5.9% | 0.00% | -100.0% |
| Q4 2019 | $17,902,000 | +56.8% | 1,201,498 | +7.9% | 0.00% | – |
| Q3 2019 | $11,416,000 | +0.6% | 1,113,812 | +4.0% | 0.00% | – |
| Q2 2019 | $11,352,000 | +5.4% | 1,070,914 | +39.0% | 0.00% | – |
| Q1 2019 | $10,774,000 | +47.1% | 770,635 | +6.9% | 0.00% | – |
| Q4 2018 | $7,324,000 | +35.5% | 720,899 | +60.0% | 0.00% | – |
| Q3 2018 | $5,406,000 | +3.2% | 450,456 | +4.9% | 0.00% | – |
| Q2 2018 | $5,239,000 | +91.1% | 429,456 | +54.3% | 0.00% | – |
| Q1 2018 | $2,742,000 | +9.6% | 278,379 | +55.3% | 0.00% | – |
| Q4 2017 | $2,501,000 | +134.0% | 179,218 | +84.5% | 0.00% | – |
| Q3 2017 | $1,069,000 | +35.0% | 97,118 | -3.2% | 0.00% | – |
| Q2 2017 | $792,000 | -53.3% | 100,337 | -32.2% | 0.00% | – |
| Q1 2017 | $1,696,000 | -0.1% | 148,072 | +1.6% | 0.00% | – |
| Q4 2016 | $1,698,000 | -13.4% | 145,803 | -0.4% | 0.00% | – |
| Q3 2016 | $1,961,000 | -20.7% | 146,452 | +17.4% | 0.00% | – |
| Q2 2016 | $2,473,000 | +331.6% | 124,787 | +265.6% | 0.00% | – |
| Q1 2016 | $573,000 | – | 34,128 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 694,232 | $8,532,000 | 5.82% |
| P.A.W. CAPITAL CORP | 400,000 | $4,916,000 | 4.34% |
| Telemetry Investments, L.L.C. | 128,848 | $1,584,000 | 2.68% |
| Trellus Management Company, LLC | 206,404 | $2,537,000 | 2.09% |
| KNOTT DAVID M | 295,035 | $3,626,000 | 1.64% |
| 683 Capital Management, LLC | 2,683,600 | $32,982,000 | 1.56% |
| INTERWEST VENTURE MANAGEMENT CO | 764,918 | $9,401,000 | 1.17% |
| TOWERVIEW LLC | 130,000 | $1,598,000 | 1.14% |
| Vivo Capital, LLC | 1,791,257 | $22,015,000 | 0.98% |
| Altium Capital Management LP | 197,500 | $2,427,000 | 0.91% |